U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008001) titled 'Assessment of DOT Spectacles in Chinese Children Extension' on May 14.
Brief Summary: This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Juvenile Myopia
Myopia
Intervention:
DEVICE: Novel spectacle lens design
Use of spectacle lenses may reduce the rate of progression of juvenile myopia
Recruitment Status: RECRUITING
Sponsor...